Introduction to the Capricor Class Action Lawsuit
The Capricor seeks to represent purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between October 9, 2024 and July 10, 2025, inclusive (the “Class Period”). Captioned Leong v. Capricor Therapeutics, Inc., No. 25-cv-01815 (S.D. Cal.), the Capricor class action lawsuit charges Capricor and Capricor’s CEO with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Capricor class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].
Lead plaintiff motions for the Capricor class action lawsuit must be filed with the court no later than September 15, 2024.
Please see the various investor resources below for an additional wealth of information.
In this guide, we provide a timeline of events for the entire duration of a typical securities class action lawsuit like the Capricor class action lawsuit, with approximately how long each step takes so you will have a better understanding of the timing of events in the Capricor lawsuit.
Understanding Securities Fraud Class Action Lawsuits
Securities fraud class action lawsuits represent a significant legal mechanism for investors who have suffered financial losses due to corporate malfeasance. These lawsuits, such as the Capricor lawsuit, typically arise when a company or its executives engage in deceptive practices that mislead investors about the company’s financial health or prospect.
The goal of such litigation is to hold the perpetrators accountable and secure compensation for the affected investors. Securities fraud encompasses a range of activities, including insider trading, false financial statements, and misleading disclosures, all of which can severely impact market integrity and investor confidence.
In a class action context, a group of investors collectively brings the lawsuit against the defendant, which could be a corporation or its executives. This collective approach is particularly powerful in the securities realm because it allows individual investors, who might not have the resources to pursue litigation on their own, to band together and seek justice.
The class action mechanism ensures that the legal process is efficient and that the interests of all affected investors are represented.
The complexity of securities fraud class action lawsuits requires plaintiffs to navigate a labyrinth of legal standards and procedural hurdles. One of the most significant challenges is surviving a motion to dismiss, a legal maneuver by the defendants to have the case thrown out before it reaches trial.
Understanding the nuances of the Capricor lawsuit is crucial for any stakeholder involved, as it sets the stage for the strategic decisions that will follow. In the case of the Capricor class action lawsuit, these elements come into sharp focus, highlighting the importance of a well-crafted legal strategy.
Allegations in the Capricor Class Action Lawsuit
Capricor is a clinical-stage biotechnology company that engages in the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”) and other diseases.
The Capricor class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose adverse facts concerning its four-year safety and efficacy data from its Phase 2 HOPE-2 trial study and gave the false impression that Capricor could obtain first approval for DMD cardiomyopathy.
The Capricor class action lawsuit alleges that on May 5, 2025, Capricor announced it had completed its mid-cycle review meeting with the U.S. Food and Drug Administration (“FDA”) on deramiocel for the treatment of DMD and that no significant deficiencies were identified by the Review Committee and that the package is on track for a Prescription Drug User Fee Act action date of August 31, 2025.
According to the complaint, the FDA also confirmed its intent to hold an advisory committee meeting. The Capricor class action lawsuit alleges that on this news, the price of Capricor stock fell more than 29%.
The Capricor class action lawsuit further alleges that on June 20, 2025, Stat News reported that Vinjay Prasad, the director of the FDA’s Center for Biologics Evaluation and Research, canceled the advisory committee meeting regarding deramiocel due to being “skeptical of the treatment” and uncertain about the drug’s efficacy and safety. On this news, the price of Capricor stock fell more than 30%, according to the complaint.
Then, on July 11, 2025, the Capricor class action lawsuit also alleges that Capricor announced it received a Complete Response Letter from the FDA denying Capricor’s Biologics License Application for deramiocel, citing it did not meet the statutory requirement for substantial evidence of effectiveness and the need for additional clinical data. On this news, the price of Capricor stock fell nearly 33%, according to the complaint.
Who is Affected by the Capricor Class Action Lawsuit?
The Capricor class action lawsuit primarily affects investors who purchased shares and suffered a loss during the period in which the alleged misconduct occurred. If you invested in 3D Systems during this time, you could be part of the affected class and eligible for compensation if the lawsuit succeeds.
Identifying whether you are part of the affected group is crucial for understanding your rights and potential benefits. The Capricor class action lawsuit may involve a specific time frame and set of circumstances that define the class of investors who can participate. Knowing these details will help you determine your eligibility and take appropriate action.
In addition to investors, the lawsuit can also impact the company’s executives, board members, and other stakeholders. The outcome of the lawsuit could influence Capricor’s reputation, financial stability, and future operations, affecting all parties associated with the company. Staying informed about the lawsuit’s progress is essential for anyone connected to Capricor.
Lead Plaintiff Appointment in the Capricor Lawsuit: Approximately Four Months After Initial Complaint Was Filed
When a securities class action is filed such as the 3D Systems class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the 3D Systems lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.
At the end of the sixty days, the court can rule on the lead plaintiff’s motion just on the pleading filed with the court, or the judge may set a hearing on the motion for 30–45 days after the sixty-day expiration. If a hearing is held, the judge will issue an order afterwards appointing a lead plaintiff which could be a couple weeks to a couple months.
Regardless, the PSLRA states that not later than 90 days after the initial filing and notice the court must consider the lead plaintiff’s motions and must consolidate all the related cases filed before issuing an order on the lead plaintiff. Thus, from the initial filing until a lead plaintiff is appointed, about four months have passed.
Filing of a Consolidated Complaint: Approximately Six Months After Initial Filing of the Capricor Lawsuit
After the appointment of lead plaintiff, the court will enter a scheduling order which will include a time, usually about 60 days, for the lead plaintiff to file a consolidated complaint consolidating the allegations all complaints along with any new additional allegations.
The Defendants Motion to Dismiss: Decided Nearly a Year After the Initial Capricor Class Action Lawsuit Was Filed
In the same scheduling order, the court will also set a time for the defendants to file a motion to dismiss and schedule a briefing and possibly a hearing on the motion once the briefing is completed. The defendants may have 45 to 60 days to file the motion to dismiss and then the briefing schedule is typically around 60 days, and the court will then enter an order either granting or denying the motion to dismiss.
Thus, by the time defendants’ motion to dismiss is decided nearly a year has passed since the filing of the original complaint and could be possibly longer given the court’s schedule.
Completion Of Discovery: Two-and-a-Half-Years After Initial Filing of the Capricor Class Action Lawsuit
If the defendant’s motion to dismiss is denied, the parties will move into the discovery phase including the exchange of documents, request for admissions, interrogatories, depositions, and third-party subpoenas, among others.
Settlement Negotiation and Mediation
By now two-and-a-half to three years have passed since the initial filing of the 3D Systems class action lawsuit. However, it is at this point that nearly all securities class actions result in a settlement, but that process takes time also. Once the parties have reached an agreement, it will have to be preliminarily approved by the court with notice to shareholders with the right to object, obtain final approval of the settlement, and then the claims process begins.
Usually, a third-party administrator is hired to administer the common fund. If the parties have complied with all the steps for approval, the judge will approve the distribution of the settlement fund by the claim’s administrator. You will receive a court-appointed notice and have to send in a claim form confirming your purchases and sales. This process alone can take up to a year and therefore it may be four years until the case is finally resolved.
Steps to Take to Protect Your Investment
Gathering and Organizing Relevant Evidence
In a securities class action lawsuit just like the Capricor class action lawsuit, evidence is the cornerstone of building a compelling case. For shareholders, gathering and organizing relevant evidence is a critical step in substantiating claims of corporate misconduct.
The evidence typically revolves around documents and communications that demonstrate the company’s misrepresentations or omissions, as well as the financial harm suffered by shareholders. Below are some steps you should take:
- Compile all financial statements, press releases, analyst reports, emails, and any internal documents that shed light on the alleged wrongdoing alleged in the Capricor class action lawsuit.
- Meticulously document your investment history with the Capricor, including dates of stock purchases and sales, quantities, and prices. This information is crucial for calculating damages and proving that the shareholder suffered financial losses as a result of the company’s actions.
- Maintaining detailed records not only strengthens the individual’s position in the lawsuit but also contributes to the overall strength of the Capricor lawsuit, by providing a clear picture of the impact on shareholders.
- Organizing this evidence in a systematic manner is equally important. Shareholders can create a comprehensive file of all relevant documents, categorized by type and date, to facilitate easy retrieval and review by legal counsel.
This preparation not only aids in the efficient prosecution of the Capricor lawsuit, but also demonstrates the shareholder’s commitment and readiness to actively participate in the litigation process.
By thoroughly gathering and organizing evidence, shareholders lay a solid foundation for holding corporations accountable and seeking redress for their financial injuries.
Staying Informed: Monitoring Case Developments
In the fast-paced environment of securities class action lawsuits, staying informed about case developments is crucial for shareholders. As the Capricor class action lawsuit, moves forward, new information and events can significantly impact the strategy and potential outcomes. Capricor shareholders must actively monitor key milestones, such as court rulings, settlement negotiations, and any changes in the legal landscape. Keeping abreast of these developments ensures that shareholders are well-positioned to make timely and informed decisions.
Effective communication with legal counsel is essential for staying updated on case developments. Attorneys provide regular updates and analyses of the ongoing proceedings, helping shareholders understand the implications of each development. This information is vital for assessing the potential risks and benefits of different courses of action, such as whether to accept a settlement offer or continue pursuing the Capricor class action lawsuit.
By maintaining open lines of communication with their legal team, shareholders can remain engaged and proactive throughout the litigation process.
Shareholders can also benefit from following news sources and industry reports related to the Capricor class action lawsuit and the defendant company. These sources can provide valuable insights into broader market trends, regulatory changes, and public perceptions that may influence the case. By staying informed, shareholders can better anticipate shifts in the legal and financial landscape, enabling them to adapt their strategies and protect their interests effectively.
In securities class actions, knowledge is power, and staying informed is a key component of successful participation.
Contact Timothy L. Miles Today About an Biohaven Class Action Lawsuit
If you suffered substantial losses and wish to serve as lead plaintiff of the Capricor class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected]. (24/7/365).
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com
Facebook Linkedin Pinterest youtube
